Neurology Advisor (@NeuroAdvisor) header
Neurology Advisor (@NeuroAdvisor) profile picture

Neurology Advisor provides health care professionals with comprehensive information and clinical news on the management of neurological conditions.

New York, NY
Joined March 2014
Photo by Neurology Advisor (@NeuroAdvisor)Photo by Neurology Advisor (@NeuroAdvisor)Photo by Neurology Advisor (@NeuroAdvisor)Photo by Neurology Advisor (@NeuroAdvisor)Photo by Neurology Advisor (@NeuroAdvisor)Photo by Neurology Advisor (@NeuroAdvisor)Photo by Neurology Advisor (@NeuroAdvisor)Photo by Neurology Advisor (@NeuroAdvisor)Photo by Neurology Advisor (@NeuroAdvisor)Photo by Neurology Advisor (@NeuroAdvisor)
Medicine is changing & so are we: more digital, more personalized & more resources. Your trusted source for the information you need, when you need it, is here with a new look & feel – see the all-new @NeuroAdvisor, part of the @HaymarketMedNet neurologyadvisor.com/
1
1
1
Lecanemab administration was associated with distinct patterns of change across various plasma #biomarkers, indicating that markers of #amyloid clearance may not directly correlate with the extent of cognitive decline. bit.ly/4zNtHZR
1
44
A harmonized visual reading framework for tau positron emission tomography scans in #AlzheimerDisease improved identification of tau-positive individuals at earlier disease stages while demonstrating strong agreement across 4 #radiotracers. bit.ly/4zE9Hca
59
The combination of baseline digital #cognitive phenotyping and elevated plasma p-tau217 levels effectively identifies asymptomatic older adults at the highest risk for accelerated #TauAccumulation and near-term cognitive deterioration. bit.ly/3UyC4ZN
24
Among older adults without established #dementia, the administration of repetitive transcranial magnetic stimulation was associated with modest, immediate enhancements in working memory and #cognitive flexibility. bit.ly/4ea2gAR
1
107
#MSToronto2026 - Helen Tremlett, PhD, discusses the relationship between #cardiovascular disease and the prodromal period of #MultipleSclerosis. bit.ly/47PugWH
31
#MSToronto2026 - Among patients with #MOGAD, treatment with #tocilizumab, compared with rituximab, resulted in near-complete relapse suppression and demonstrated less between-study heterogeneity. bit.ly/3VZLoXc
90
#MSToronto2026 - Kristen Krysko, MD, suggests that modern #fertility treatments and appropriately timed disease-modifying therapies may not increase MS #relapse risk. bit.ly/3U6WMA0
94
#MSToronto2026 - Stijn Denissen, PhD, discusses the historical context and current applications of artificial intelligence in the #MultipleSclerosis landscape. See the full interview here 🎤 bit.ly/4siwuY9 #AI #Neurology #Imaging
67